Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT05588609 |
Title | Study Evaluating Zenocutuzumab in Patients With or Without Molecularly Defined Cancers |
Recruitment | Active, not recruiting |
Gender | both |
Phase | Phase II |
Variant Requirements | No |
Sponsors | Merus N.V. |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
The Oncology Institute of Hope & Innovation | Whittier | California | 90603 | United States | Details | |
Florida Cancer Specialists | Lake Mary | Florida | 32746 | United States | Details | |
The Center for Cancer and Blood Disorders | Bethesda | Maryland | 20817 | United States | Details | |
Memorial Sloan Kettering Cancer Center | New York | New York | 10065 | United States | Details | |
TriHealth Cancer Institute | Cincinnati | Ohio | 45220 | United States | Details | |
University Hospitals - Seidman Cancer Center | Cleveland | Ohio | 44106 | United States | Details | |
Northwest Medical Specialties | Tacoma | Washington | 98405 | United States | Details |